I anticipate that the FDA will next grant Gilead a 2-week combo trial with remdesivir and an anti-inflamatory, since CytoDyn has apparently rejected being involved.
And, I anticipate the FDA will quickly rubber stamp an approval. It's clear from Fauci's statements that this is the direction they are going.